Class 4 Medicines Defect Notification: Sandoz Limited, Co-amoxiclav Powder For Oral Suspension 250/62.5 Mg/5ml, El(26)a/46

Recalling firm

Sandoz Limited

Reason

Sandoz Limited have informed the MHRA of errors in the dosing table in the Summary of Product Characteristics (SmPC) for Co-amoxiclav 250/62.5 mg/5 ml Powder for Oral Suspension.

Classification

Class III

Category

drug recall

Country

United Kingdom

Agency

UK Medicines and Healthcare products Regulatory Agency

Recall date

2026-11-05

Status

Ongoing

Distribution

United Kingdom

Official recall notice from UK Medicines and Healthcare products Regulatory Agency

Recall details on Nibble Recalls: https://trynibble.app/recalls/09e324e3-7bf0-4032-a1c5-fbfb0ec858fc